FREDUN PHARMACEUTICALS
|
The Current P/E Ratio of FREDUN PHARMACEUTICALS is 48.89.
| Share Price | ₹1,109.8 | Aug 04,2026 |
| Market Cap | ₹1,831.1 Cr | |
| Earnings-TTM | ₹37.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 48.89x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of FREDUN PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,831.1 Cr] as on Aug 04,2026
(/) Earnings [ ₹37.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 48.89x ]
Thus, for FREDUN PHARMACEUTICALS , the investors are currently willing to pay 48.89 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of FREDUN PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of FREDUN PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of FREDUN PHARMACEUTICALS
PE Ratio Performance Analysis for FREDUN PHARMACEUTICALS
- FREDUN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2025 averaged 22.02x.
- FREDUN PHARMACEUTICALS 's operated at median p/e ratio of 28.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, FREDUN PHARMACEUTICALS 's p/e ratio peaked in Mar2026 at 28.05x.
- FREDUN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2025 of 15.99x.
How does FREDUN PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| FREDUN PHARMACEUTICALS | 37.45 | 48.89 | 1,831.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 38.63 | 470,270.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 75.97 | 222,224.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 88.74 | 191,325.0 |
| CIPLA LTD | 3,364.84 | 34.81 | 117,139.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 30.57 | 96,876.6 |
| MANKIND PHARMA LTD | 2,055.11 | 49.46 | 101,638.0 |
| LUPIN LTD | 5,355.47 | 20.29 | 108,639.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.20 | 111,571.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 26.03 | 91,128.4 |
| LAURUS LABS LTD | 1,090.76 | 90.92 | 99,174.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs FREDUN PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 20.29x |
| Max industry PE | 90.92x |
| Median industry PE | 38.63x |
| Average industry PE | 47.86x |
You may also like the below Video Courses